SEAGEN INC's ticker is SGEN and the CUSIP is 81181C104. A total of 524 filers reported holding SEAGEN INC in Q4 2022. The put-call ratio across all filers is 0.26 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $200,450,353 | +16.7% | 944,852 | +5.9% | 0.04% | +18.2% |
| Q2 2023 | $171,765,931 | -6.1% | 892,476 | -1.2% | 0.03% | -8.3% |
| Q1 2023 | $182,893,378 | +59.9% | 903,311 | +1.5% | 0.04% | +50.0% |
| Q4 2022 | $114,402,558 | -4.2% | 890,223 | +2.0% | 0.02% | -11.1% |
| Q3 2022 | $119,475,000 | -25.2% | 873,162 | -3.3% | 0.03% | -20.6% |
| Q2 2022 | $159,705,000 | +15.0% | 902,591 | -6.4% | 0.03% | +41.7% |
| Q1 2022 | $138,881,000 | -5.7% | 964,120 | +1.2% | 0.02% | 0.0% |
| Q4 2021 | $147,348,000 | -9.4% | 953,084 | -0.5% | 0.02% | -17.2% |
| Q3 2021 | $162,589,000 | +16.9% | 957,539 | +8.7% | 0.03% | +16.0% |
| Q2 2021 | $139,091,000 | +16.6% | 880,997 | +2.6% | 0.02% | +13.6% |
| Q1 2021 | $119,257,000 | -19.7% | 858,828 | +1.2% | 0.02% | -24.1% |
| Q4 2020 | $148,576,000 | – | 848,327 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Baker Brothers Advisors | 46,912,266 | $6,419,005,000 | 42.04% |
| Ally Bridge Group (NY) LLC | 92,506 | $12,658,000 | 8.36% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 166,200 | $22,739,000 | 7.29% |
| Eagle Health Investments LP | 174,902 | $23,932,000 | 5.49% |
| Avoro Capital Advisors LLC | 1,865,000 | $255,188,000 | 4.71% |
| Lagoda Investment Management, L.P. | 47,955 | $6,562,000 | 4.67% |
| Nan Fung Group Holdings Ltd | 47,096 | $6,444,000 | 4.11% |
| Ikarian Capital, LLC | 150,000 | $20,525,000 | 4.09% |
| Antara Capital LP | 946,100 | $129,455,000 | 3.42% |
| SECTOR GAMMA AS | 84,730 | $11,594,000 | 2.99% |